The quest for effective treatment of multiple myeloma continues, with a focus on current immunotherapies and new approaches. Survival rates have improved, but the disease remains incurable.

Promising advancements include monoclonal antibodies and checkpoint inhibitors, which enhance T cell activity. Emerging treatments like bispecific antibodies and CAR T cell therapy show high efficacy. Future strategies aim to improve patient outcomes and explore potential cures.

AI has been used for both descriptions and subtitles, even though it has been checked, there may be errors.